Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer?

Baker, Simon C; Mason, Andrew S; Southgate, Jennifer

Baker, Simon C; Mason, Andrew S; Southgate, Jennifer.

Afiliação

Baker SC; Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, UK. Electronic address: simon.baker@york.ac.uk.
Mason AS; Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, UK.
Southgate J; Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, UK.

Eur Urol ; 79(3): 435-436, 2021 03.

Article em En | MEDLINE | ID: mdl-33203550

Assuntos

Proteínas de Ligação a DNA/genética; Proteínas de Neoplasias/genética; Neoplasias da Bexiga Urinária; Humanos; Mutação; Neoplasias da Bexiga Urinária/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Proteínas de Ligação a DNA / Proteínas de Neoplasias Limite: Humans Idioma: En Revista: Eur Urol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google